but also superficial punctate keratitis and pronounced conditions of filamentary keratitis. For tearing deficiencies, as occur in sicca syndrome, not only a reduction of the aqueous phase of the ...
The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.
Three eyes had stage 1 keratopathy with a history of previous herpes zoster keratitis, superficial punctate keratitis, and subepithelial haze or scarring in 2 eyes and filamentary keratopathy in 1 ...
The term scleritis describes a chronic inflammation that involves the outermost coat and skeleton of the eye. Disease can be isolated to the eye, but in up to half of affected individuals it ...
AKANTIOR (polihexanide) is the first and only medicinal product for the treatment of acanthamoeba keratitis – a rare, severe eye infection that often results in blindness and eye loss The ...